Choueiri, T. K., Cheng, S., Qu, A. Q., Pastorek, J., Atkins, M. B., & Signoretti, S. (2012). Carbonic anhydrase IX as a potential biomarker of efficacy in metastatic clear-cell renal cell carcinoma patients receiving sorafenib or placebo: Analysis from the treatment approaches in renal cancer global evaluation trial (TARGET). Urol Oncol.
Styl ChicagoChoueiri, Toni K., Suchun Cheng, Angela Q. Qu, Jaromir Pastorek, Michael B. Atkins, a Sabina Signoretti. "Carbonic Anhydrase IX As a Potential Biomarker of Efficacy in Metastatic Clear-cell Renal Cell Carcinoma Patients Receiving Sorafenib or Placebo: Analysis From the Treatment Approaches in Renal Cancer Global Evaluation Trial (TARGET)." Urol Oncol 2012.
Citace podle MLAChoueiri, Toni K., et al. "Carbonic Anhydrase IX As a Potential Biomarker of Efficacy in Metastatic Clear-cell Renal Cell Carcinoma Patients Receiving Sorafenib or Placebo: Analysis From the Treatment Approaches in Renal Cancer Global Evaluation Trial (TARGET)." Urol Oncol 2012.